McNeil Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Philadelphia PA United States (1933)
Status: Acquired by Johnson and Johnson (1959)

Organization Overview

First Clinical Trial
1999
NCT00840242
First Marketed Drug
1945
sulfacetamide (sultrin)
First NDA Approval
1945
sulfacetamide (sultrin)
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Global Medical Affairs & Clinical Research, McNeil AB, Sweden | MCNEIL | Mc Neil AB | MCNEIL CONS | MCNEIL CONSUMER | McNeil Consumer Healthcare Division of Mc-Neil-PPC, Inc. | McNeil Consumer Healthcare USA | McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. | MCNEIL PED | McNeil UK